Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

NCT00795665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Glioma

Interventions

DRUG: bevacizumab
DRUG: carmustine

Sponsor

University of California, Davis

Collaborators

[object Object]
[object Object]